Literature DB >> 9007687

Tautomerism of xanthine and alloxanthine: a model for substrate recognition by xanthine oxidase.

B Hernández1, M Orozco, F J Luque.   

Abstract

Tautomerism of neutral xanthine and alloxanthine has been examined both in the gas phase and in aqueous solution. The tautomeric preference in the gas phase has been studied by means of semiempirical and ab initio quantum-mechanical computations with inclusion of correlation effects at the Møller-Plesset level, and from density-functional calculations. The influence of solvent on the relative stability between tautomers has been estimated from self-consistent reaction field calculations performed with different models. The results provide a detailed picture of tautomerism for these biologically relevant purine bases. The functional implications in the recognition by xanthine oxidase are analyzed from inspection of the interaction patterns of the most stable tautomeric forms. A model for the recognition of these purine derivatives in the enzyme binding site is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9007687     DOI: 10.1007/bf00134177

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  18 in total

1.  PSEUDOFEEDBACK INHIBITION OF PURINE SYNTHESIS BY 6-MERCAPTOPURINE RIBONUCLEOTIDE AND OTHER PURINE ANALOGUES.

Authors:  R J MCCOLLISTER; W R GILBERT; D M ASHTON; J B WYNGAARDEN
Journal:  J Biol Chem       Date:  1964-05       Impact factor: 5.157

2.  The specificity of xanthine oxidase.

Authors:  V H Booth
Journal:  Biochem J       Date:  1938-03       Impact factor: 3.857

3.  An SCF Solvation Model for the Hydrophobic Effect and Absolute Free Energies of Aqueous Solvation.

Authors:  C J Cramer; D G Truhlar
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

4.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

5.  The reductive half-reaction of xanthine oxidase. Identification of spectral intermediates in the hydroxylation of 2-hydroxy-6-methylpurine.

Authors:  R B McWhirter; R Hille
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

6.  Oxidation of N-methyl substituted hypoxanthines, xanthines, purine-6,8-diones and the corresponding 6-thioxo derivatives by bovine milk xanthine oxidase.

Authors:  F Bergmann; L Levene
Journal:  Biochim Biophys Acta       Date:  1976-05-13

Review 7.  The reaction mechanism of oxomolybdenum enzymes.

Authors:  R Hille
Journal:  Biochim Biophys Acta       Date:  1994-03-08

8.  Mechanisms of inactivation of molybdoenzymes by cyanide.

Authors:  M P Coughlan; J L Johnson; K V Rajagopalan
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

9.  The structure of the inhibitory complex of alloxanthine (1H-pyrazolo[3,4-d]pyrimidine-4,6-diol) with the molybdenum centre of xanthine oxidase from electron-paramagnetic-resonance spectroscopy.

Authors:  T R Hawkes; G N George; R C Bray
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

10.  The kinetic mechanism of xanthine dehydrogenase and related enzymes.

Authors:  M P Coughlan; K V Rajagopalan
Journal:  Eur J Biochem       Date:  1980-03
View more
  3 in total

1.  A hydrophobic similarity analysis of solvation effects on nucleic acid bases.

Authors:  Jordi Muñoz-Muriedas; Xavier Barril; José María López; Modesto Orozco; Francisco Javier Luque
Journal:  J Mol Model       Date:  2006-09-21       Impact factor: 1.810

2.  Validation of a dual LC-HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics.

Authors:  Ilya Gertsman; Jon A Gangoiti; Bruce A Barshop
Journal:  Metabolomics       Date:  2014-04-04       Impact factor: 4.290

3.  Tautomeric equilibria in 8-oxopurines: implications for mutagenicity.

Authors:  D Venkateswarlu; J Leszczynski
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.